Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Medullary × fludarabine × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 66 Leukemia 63 Leukemia, Lymphocytic, Chronic, B-Cell 59 Myelodysplastic Syndromes 49 Lymphoma 44 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Lymphoma, Non-Hodgkin 41 Multiple Myeloma 37 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35 Hodgkin Disease 33 Melanoma 25 Hematologic Neoplasms 23 Myeloproliferative Disorders 16 Recurrence 15 Neoplasms 15 Neoplasm Metastasis 15 Lymphoma, Follicular 14 Primary Myelofibrosis 13 Lymphoma, Mantle-Cell 13 Neoplasms, Plasma Cell 12 Lymphoma, Large B-Cell, Diffuse 12 Skin Neoplasms 11 Graft vs Host Disease 10 Burkitt Lymphoma 10 Lymphoma, B-Cell, Marginal Zone 9 Anemia, Refractory, with Excess of Blasts 9 Lymphoma, B-Cell 8 Breast Neoplasms 8 Ovarian Neoplasms 7 Leukemia, Prolymphocytic 7

Interventions

vandetanib 9 cabozantinib 4 selpercatinib 3 Sunitinib 2 Sorafenib 2 yeast-CEA vaccine 1 tanespimycin 1 pralsetinib 1 pembrolizumab 1 pazopanib 1 lenvatinib 1 Vorinostat 1 Temozolomide 1 Pharmacogenomic Testing 1 Magnetic Resonance Spectroscopy 1 Lithium Carbonate 1 Irinotecan 1 Gefitinib 1 Ferrosoferric Oxide 1 Capecitabine 1 Bortezomib 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡